Aller au contenu principal
Profil bibliographique

Greta Catani

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

19Publications signalées
68Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Colorectal Cancer Surgical TreatmentsGastric Cancer Management and OutcomesGenetic factors in colorectal cancerColorectal Cancer Treatments and StudiesColorectal Cancer Screening and Detection

Les publications récentes

2026 article OpenAlex

Emerging trends in early-onset gastrointestinal cancers - a comparative review with late-onset cancers

Greta Catani, Luz Divina Juez, Juan M O´Connor, Antonino Spinelli et autres

INTRODUCTION: Early-onset gastrointestinal (GI) cancers, defined as those diagnosed before the age of 50, are increasing worldwide, whereas the incidence of late-onset GI cancers has stabilized or declined. These trends highlight the need to better understand age-related differences in disease biology and …

es, it (code pays fourni par la source)

0 citations Expert Review of Anticancer Therapy
Accès ouvert 2026 article OpenAlex

Early-onset colorectal cancer: a comprehensive review reframing hypotheses and defining research priorities

Greta Catani, Juan Manuel O’Connor, Antonino Spinelli, José Perea

PURPOSE: Early-onset colorectal cancer (EOCRC), defined as colorectal cancer diagnosed before the age of 50 years, is increasing worldwide and represents a growing clinical and public health challenge. Whether EOCRC constitutes a biologically distinct entity remains uncertain, and current diagnostic and therapeutic …

ar, it, es (code pays fourni par la source)

2 citations International Journal of Colorectal Disease
Accès ouvert 2025 article OpenAlex

Optimizing early-phase immunotherapy trials: the role of biomarker enrichment strategies

Greta Catani, Oriol Mirallas, Vicky Sánchez-Pérez, Paolo Nucíforo et autres

Immune checkpoint inhibitors have revolutionized the treatment of solid tumors; however, their clinical efficacy remains limited to a subset of patients. Novel immunotherapy agents are being investigated in phase I clinical trials, with an increasing focus on biomarker selection strategies to optimize …

es, ar, us, br (code pays fourni par la source)

7 citations Frontiers in Immunology
Accès ouvert 2025 article OpenAlex

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Alessandro Audisio, Chiara Gallio, Vaneja Velenik, Hélène Meillat et autres

Importance: This was a clinical study of total neoadjuvant therapy (TNT) for rectal cancer. Objective: To assess the use and outcomes of TNT in routine practice. Design, Setting, and Participants: This international, multicenter study was conducted at 61 centers across 21 countries …

be, it, si, fr, mx, es, pt, hr, tr, ar, il, nl, lb, lt, de, cy, ro, cz, gb, pe, gr, us (code pays fourni par la source)

25 citations JAMA Oncology
Accès ouvert 2025 article OpenAlex

Emerging Immunotherapy Targets in Early Drug Development

D. Morchón Araujo, Greta Catani, Oriol Mirallas, G. Pretelli et autres

Immunotherapy has significantly changed the treatment paradigm for solid tumors, with immune checkpoint inhibitors now established in the management of many malignancies. Despite initial success, durable responses remain limited to a subset of patients, often less than 30%, due to both intrinsic …

es, ar (code pays fourni par la source)

11 citations International Journal of Molecular Sciences
Accès ouvert 2025 article OpenAlex

Targeted therapies in neoadjuvant treatment for gastroesophageal cancer

Berenice Freile, Andrés Rodríguez, Greta Catani, Marcos Bortz et autres

Gastroesophageal cancers are among the most prevalent cancers globally and represent the third leading cause of cancer-related mortality worldwide. Surgical resection remains the primary curative approach for localised and locally advanced stages, but its effectiveness is limited for locally advanced diseases, evidenced …

ar (code pays fourni par la source)

0 citations ecancermedicalscience
2025 article OpenAlex

Changing oncology training in Latin America: A mentorship program design and implementation.

Marcos Bortz, Federico Waisberg, Federico Losco, Andrés Rodríguez et autres

e21031 Background: Mentorship is a valuable aspect of professional development in oncology. It has been associated with an increase in job satisfaction, self-confidence and career success, while contributing to the reduction of burnout. To date, there are no published examples of the …

ar (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2025 article OpenAlex

Tumores Neuroendocrinos Gastroenteropancreáticos

Andrés Rodríguez, Greta Catani, Oscar Andriani, Gerardo Arroyo et autres

Los tumores neuroendocrinos (TNEs) representan un grupo heterogéneo de neoplasias, caracterizadas por una amplia variabilidad en su comportamiento clínico, biológico y molecular. Esta diversidad, tanto a nivel de presentación como de respuesta a los tratamientos, representa un desafío significativo en la práctica …

ar, uy, br, co, es, pr (code pays fourni par la source)

0 citations Oncología Clínica
Accès ouvert 2025 article OpenAlex

Patients with Colorectal Cancer and BRAFV600E-Mutation in Argentina: A Real-World Study—The EMOGI-CRC01 Study

Greta Catani, Stéfano Kim, Federico Waisberg, Diego Enrico et autres

Background/Objectives: The BRAF-mutation is a poor prognostic factor in colorectal cancer (CRC). There is a need for real-world data in low-middle-income countries regarding clinical characteristics, outcomes, and treatment strategies. This study aims to describe progression-free survival (PFS) and in the first- and …

ar, fr (code pays fourni par la source)

1 citation Cancers
Accès ouvert 2025 preprint OpenAlex

Patients with Colorectal Cancer and BRAFV600E-Mutation in Argentina: A Real-World Study: The EMOGI-CRC01 Study

Greta Catani, Stéfano Kim, Federico Waisberg, Diego Enrico et autres

Background/Objectives: BRAF-mutation is a poor prognostic factor in colorectal cancer (CRC). There is a need for real-world data in low-middle-income countries regarding clinical characteristics, outcomes, and treatment strategies. This study aims to describe progression free survival (PFS) and overall survival (OS) in …

ar, uy (code pays fourni par la source)

0 citations Preprints.org
2025 article OpenAlex

[Hyperprogression in a patient with colorectal cancer and repair protein deficiency: a diagnostic and therapeutic challenge].

Greta Catani, Federico Esteso, Luisina Bruno, Andrés Rodríguez et autres

Metastatic colorectal cancer (mCRC) represents a significant global public health challenge. The identification of biomarkers such as microsatellite instability (MSI) and the status of mismatch repair (MMR) proteins, among others, provides crucial information for guiding therapeutic decisions and predicting prognosis. Immune checkpoint …

ar (code pays fourni par la source)

0 citations PubMed

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.